...
首页> 外文期刊>Molecular therapy: the journal of the American Society of Gene Therapy >Baculovirus GP64-pseudotyped HIV-based lentivirus vectors are stabilized against complement inactivation by codisplay of decay accelerating factor (DAF) or of a GP64-DAF fusion protein.
【24h】

Baculovirus GP64-pseudotyped HIV-based lentivirus vectors are stabilized against complement inactivation by codisplay of decay accelerating factor (DAF) or of a GP64-DAF fusion protein.

机译:通过共展示衰变加速因子(DAF)或GP64-DAF融合蛋白,可稳定杆状病毒GP64假型基于HIV的慢病毒载体,以抵抗补体失活。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The eventual development of efficient gene transfer vectors for in vivo gene delivery will require the development of a number of important new technologies such as stabilization of vectors against protective mechanisms that destroy or otherwise inactivate foreign infectious agents like gene transfer vectors. It is known that the baculovirus envelope protein GP64 of Autographa californica nucleopolyhedrovirus can efficiently pseudotype lentivirus vectors and that modified forms of the baculovirus envelope protein GP64 can also assemble efficiently into baculovirus particles to display functional foreign proteins on the baculovirus surface. In the present study we have combined these techniques to prepare HIV-based lentivirus vectors pseudotyped with GP64 envelope protein and coexpressing a fusion protein of GP64 with the complement-regulatory, decay accelerating factor (DAF, CD55). In addition, we have also prepared GP64-pseudotyped vectors in the presence of a DAF expression plasmid to allow the incorporation of DAF protein into viral particles. Our results demonstrate both the efficient expression and the high-titer production of GP64/GP64-DAF and GP64/DAF-pseudotyped particles and their stability against inactivation by human and nonhuman primate serum.
机译:最终开发用于体内基因递送的有效基因转移载体将需要开发许多重要的新技术,例如使载体针对破坏破坏或以其他方式灭活外来感染因子的保护机制的稳定机制,例如基因转移载体。已知的是,加利福尼亚州的Autographa californica核多角体病毒的杆状病毒包膜蛋白GP64可以有效地假型化慢病毒载体,并且杆状病毒包膜蛋白GP64的修饰形式也可以有效地组装成杆状病毒颗粒,以在杆状病毒表面上展示功能性外来蛋白。在本研究中,我们将这些技术结合起来,以GP64包膜蛋白假型制备基于HIV的慢病毒载体,并与补体调节,衰变加速因子(DAF,CD55)共表达GP64融合蛋白。此外,我们还在DAF表达质粒的存在下制备了GP64假型载体,以允许将DAF蛋白掺入病毒颗粒中。我们的结果证明了GP64 / GP64-DAF和GP64 / DAF假型颗粒的高效表达和高滴度生产,以及它们对抗人类和非人类灵长类动物血清失活的稳定性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号